Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Dow
Mallinckrodt
Federal Trade Commission
AstraZeneca
Novartis
Fish and Richardson
Fuji
QuintilesIMS
US Army

Generated: January 17, 2018

DrugPatentWatch Database Preview

Amphetamine resin complex; dextroamphetamine resin complex - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for amphetamine resin complex; dextroamphetamine resin complex and what is the scope of amphetamine resin complex; dextroamphetamine resin complex patent protection?

Amphetamine resin complex; dextroamphetamine resin complex
is the generic ingredient in three branded drugs marketed by Ucb Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are fifty-three drug master file entries for amphetamine resin complex; dextroamphetamine resin complex.
Summary for amphetamine resin complex; dextroamphetamine resin complex

US Patents and Regulatory Information for amphetamine resin complex; dextroamphetamine resin complex

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc BIPHETAMINE 12.5 amphetamine resin complex; dextroamphetamine resin complex CAPSULE, EXTENDED RELEASE;ORAL 010093-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ucb Inc BIPHETAMINE 20 amphetamine resin complex; dextroamphetamine resin complex CAPSULE, EXTENDED RELEASE;ORAL 010093-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ucb Inc BIPHETAMINE 7.5 amphetamine resin complex; dextroamphetamine resin complex CAPSULE, EXTENDED RELEASE;ORAL 010093-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Argus Health
McKinsey
Mallinckrodt
Boehringer Ingelheim
Merck
Covington
Baxter
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot